NCT00969436View on ClinicalTrials.gov

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 9, 2009

Primary Completion Date

February 21, 2011

Study Completion Date

February 21, 2011

Conditions
VaricellaRubellaMumpsMeasles
Interventions
BIOLOGICAL

GSK Biological's investigational MMRV vaccine 208136

Subcutaneous injection

BIOLOGICAL

Priorix™

Subcutaneous injection

BIOLOGICAL

Varilrix™

Subcutaneous injection

Trial Locations (6)

403202

GSK Investigational Site, Goa

560034

GSK Investigational Site, Bangalore

700073

GSK Investigational Site, Kolkata

Unknown

GSK Investigational Site, Chennai

GSK Investigational Site, Pune

411 011

GSK Investigational Site, Pune

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00969436 - Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM | Biotech Hunter | Biotech Hunter